GoPAPfree has announced the launch of its new customisable oral appliance therapy device, which offers an efficient and comfortable alternative to CPAP therapy with at-home moulding and implementation for obstructive sleep apnea.
O2Vent Optima is an exclusive appliance with integrated airway technology and augments the response rate to sleep apnea therapy by 40% compared to standard mouthguards.
According to clinical trials, it is the only device with a 100% response rate to snoring.
The device is 3D printed for a precise fit unique to each person.
The Food and Drug Administration (FDA)-approved O2Vent Optima is indicated for patients with mild, moderate, and severe CPAP intolerant sleep apnea and snoring, and for those with nasal obstruction and other areas of airway collapse such as from the tongue, soft palate, and lateral walls.
Estimates show that nasal obstruction affects 30%-50% of sleep apnea patients and its symptoms are increased when lying down.
The device’s airway technology helps patients to experience device-breathing as opposed to mouth breathing, enabling improved treatment with air flowing through the device.
GoPAPfree founder and O2Vent Optima inventor Christopher Hart said: “We are very excited to announce the availability of the O2Vent Optima device and its introduction into the US market.
“As a dentist and sufferer of sleep apnea, none of the existing CPAP solutions were a good fit for me. Out of desperation, I took my professional and personal knowledge to invent something that was both effective and comfortable.
“The positive impact of a consistent good night’s sleep is incredible to experience. I hope to bring that life-changing result to anyone who suffers from sleep apnea.”
Furthermore, O2Vent Optima positions the lower jaw forward to a relaxed range while also letting the integrated airway channel to bypass nasal congestion and other areas of airway collapse.